If you think building a health app is a walk in the park, think again. Turning something as seemingly simple as an app into a bona fide medical device is a marathon that runs on evidence, regulation, endless paperwork, and a budget most startups can only dream of. It’s not just about coding a slick interface or knowing your way around UX design; there’s a whole universe of rules and trials lurking beneath the surface.
When you start with the idea of making a health app, the first thing you need to wrap your head around is this whole “medical device” business. It isn’t like launching any other app. There are risk classes for medical devices – ranging from Class 1, the “lowest risk,” all the way up to devices that, let’s be honest, could mean life or death if they malfunction. If you’re in the Class 1 territory, you might have a bit of breathing room, but the rules still apply. You’re still drowning in regulations about safety, stability, and reliability. A little digital physiotherapy app, for example, is Class 1, but it still has to tick virtually every box that a more serious medical device does.
The kicker is that even software has safety issues. Think about a diabetes app that tracks insulin levels or detects crucial changes. The sensor might work fine but if the software glitches or misinforms the user, that’s a disaster waiting to happen. So, every tidbit of the system from cloud uptime to response plans for power outages has to be bulletproof. You’re not just “playing with apps,” you’re building a lifeline for someone who trusts your code with their health.
Then comes the Everest of all obstacles, the clinical trial. This is where the dream meets reality and, spoiler alert, it’s a long, expensive haul. The first step isn’t firing up patients on day one like it’s a startup sprint. Oh no. Before you’re anywhere close to releasing that app, you need to prove it works. And I mean prove it beyond reasonable doubt. This starts with a systematic review of existing science to know if your idea even holds water. If it does, then you design the trial protocol, detailing everything from patient demographics to inclusion and exclusion criteria, study duration, and outcomes you’re measuring. Every one of these steps needs sign-off from ethical committees, who, by the way, love to send your proposal from one department to another like a hot potato.
Recruitment is where dreams go to get cold. You need real people, patients who are willing to navigate your bureaucratic labyrinth and actually use your product. It’s far from easy. Physicians have to agree to enroll their patients, explain the study – something that takes valuable time they may not have – and patients themselves need time to think it over, which means delays and a mountain of paperwork. The entire process is a dance of ethics, logistics, and regulation.
If you think this is quick and cheap, prepare to be shocked. The clinical trial alone can easily cost north of 200,000 euros, and that’s just the tip of the iceberg. You have your quality management system, information security compliance, regulatory submissions, and staff to pay, including those rare species called “risk managers.” And no, 50 euros for a subscription won’t cover this. If you price your app at pocket change, good luck surviving beyond the free trial.
What baffles me the most is the disconnect between what people expect and what this process demands. Patients want innovation, but they also want cheap, accessible solutions. The health system expects products to be safe, reliable, and effective but often ties the hands of developers with labyrinthine rules that might protect data like Fort Knox but alienate users with unnecessarily complex logins, password changes, and two-factor authentication hoops that many find too daunting.
And while tech geeks like us might cringe at password hurdles as “daily life,” for large swaths of the population, especially elderly users, it’s a nightmare. Accessibility and usability on both fronts, the medical device and the patient interface, are critical but often sidelined in the name of security. The result? Drop-offs, frustration, and missed opportunities to actually improve patient outcomes.
Then there’s the elephant in the room: cost. If prevention is key in healthcare, why does the system hesitate to fund apps or digital programs aimed at it? You’ve got patients who aren’t even “sick” yet, so their treatments aren’t covered by insurance. And despite the swelling digital health waves, the economics are still gloomy. Digging into health economic studies, you see the chicken-and-egg problem. Prevention saves money, but only in the long run and with too many variables to measure neatly. The current structures favor curing sickness, not preventing it, which might mean digital health’s biggest potential sits in the gaps where funding is weakest.
And that’s not even mentioning the many digital health companies that have gone bankrupt despite ticking every regulatory box. The path to market is littered with good intentions and high costs, and survival is a staggering challenge even for those who make it through.
On the regulatory front, we’ve embraced pharma-style randomized controlled trials (RCTs) as the “gold standard.” But as much as RCTs are scientifically rigorous, they can feel artificial. Imagine trying to measure how an app performs in a lab setting, completely detached from real life. Real-world data, where patients interact with the product in messy, unpredictable ways, might actually be more telling. But regulators, like those at BFARM, aren’t quite ready to accept that just yet.
Healthcare professionals also need a crash course in prescribing digital tools. Doctors trained to deal with pills and injections are now expected to diagnose which app fits your back pain or anxiety disorder. With 40-plus digital health apps (DIGAs) on the market now, choosing the right one is no easy feat for anyone, least of all an overworked physician.
All this boils down to a colossal balancing act between safety, accessibility, cost, and usability. We want smart, effective digital tools in healthcare. We also want them affordable, easy to use, and integrated seamlessly into existing treatment pathways. But right now, these demands pull in different directions, making progress feel like wading through treacle.
There’s hope though. The system is still learning. Regulators, companies, clinicians, and patients are figuring out together how to make this digital health future functional rather than just theoretical. Yes, there are frustrations and bureaucratic madness, but the potential to improve lives is real. If we keep our eye on the prize, and remember that patients are not lab rats but real people who need practical help, we might just find a way to make it work.
Commenting Rules: Being critical is fine, if you are being rude, we’ll delete your stuff. Please do not put your URL in the comment text and please use your PERSONAL name or initials and not your business name, as the latter comes off like spam. Have fun and thanks for your input.
Join a growing community. Every Friday I share the most recent insights from what I have been up to, directly to your inbox.
